Journal of cachexia, sarcopenia and muscle · 2026
Loss of Myonuclei and Transcriptional Activity During Diaphragm Atrophy in Critically Ill Patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Claassen Wout J, van den Berg Marloes, Shi Zhong Hua, Baelde Rianne J, Bogaards Sylvia, Bonis Luuk, Hakkeling Heleen, Bamyani Arezou, Schaaf Gerben J, Beishuizen Albertus, Dickhoff Chris, Boon Reinier A, Heunks Leo, Kirby Tyler J, Ottenheijm Coen A C
Аннотация
BACKGROUND: Diaphragm weakness frequently develops in critically ill patients and is explained by a combination of atrophy and myofiber dysfunction. Myofibers are large syncytial cells maintained by a population of myonuclei, which provide gene transcripts to a finite fiber volume, termed the myonuclear domain. Myonuclear number is a determinant of transcriptional capacity and therefore critical for diaphragm and peripheral muscle regeneration after critical illness. Changes in myonuclear number in myofibers undergoing atrophy have not been investigated in mechanically ventilated ICU patients, but they are of potential clinical importance. Our objective was to investigate if and how myonuclear number changes in the diaphragm of mechanically ventilated ICU patients and whether changes are associated with myofiber atrophy and clinical parameters.
METHODS: We used a combination of transcriptomics, immunohistochemistry and confocal microscopy to study myonuclear alterations in the diaphragm and quadriceps biopsies from mechanically ventilated ICU patients (n = 24) and non-critically ill patients (n = 10).
RESULTS: Compared to control patients, myonuclear number and myonuclear domain were reduced in critically ill patients with diaphragm myofiber atrophy (n = 14) (myonuclear number per mm of 133 [92-183] vs. 92 [83-105], p = 0.03 (slow myofibers) and 149 [118-189] vs. 88 [69-109], p = 0.004 (fast myofibers); myonuclear domain size was 44 [34-51] vs. 29 pL, p = 0.004 (slow myofibers) and 41 [39-48] vs. 27 pL, p = 0.001 (fast myofibers) of control patients and ICU patients with atrophy, respectively). Increased intrinsic apoptotic pathway activation was identified as a mechanism underlying myonuclear removal (percentage of apoptotic myonuclei of 0.64 [0.60-0.84] and 0.95 [0.84-1.2], p = 0.015 and increased percentage of activated caspase-3 positive myonuclei of 2,5 [1.6-3.3] vs. 5.7 [4.3-11], p = 0.001 in control patients and ICU patients with atrophy, respectively). Total transcriptional activity in myofibers decreased with myonuclear loss (RNA-Pol-2 Ser5 fluorescence intensity per fibre of 2.6 [2.2-3.3] vs. 5.8 [3.1-6.7] AU, p = 0.036 in control patients and ICU patients with atrophy, respectively). Furthermore, muscle stem cell number was reduced in the patients with diaphragm atrophy (PAX7 positive nuclei per myofiber of 0.10 [0.09-0.11] vs. 0.05 [0.04-0.07], p = 0.002 in control patients and ICU patients with atrophy, respectively). No correlation was found between myonuclear loss and duration or mode of mechanical ventilation.
CONCLUSIONS: We identified myonuclear loss due to intrinsic apoptotic pathway activation as a potential mechanism underlying diaphragm atrophy in mechanically ventilated patients. The loss of myonuclei may contribute to impaired regeneration of myofibers after critical illness. Duration and mode of mechanical ventilation are not the major drivers of these modifications.
METHODS: We used a combination of transcriptomics, immunohistochemistry and confocal microscopy to study myonuclear alterations in the diaphragm and quadriceps biopsies from mechanically ventilated ICU patients (n = 24) and non-critically ill patients (n = 10).
RESULTS: Compared to control patients, myonuclear number and myonuclear domain were reduced in critically ill patients with diaphragm myofiber atrophy (n = 14) (myonuclear number per mm of 133 [92-183] vs. 92 [83-105], p = 0.03 (slow myofibers) and 149 [118-189] vs. 88 [69-109], p = 0.004 (fast myofibers); myonuclear domain size was 44 [34-51] vs. 29 pL, p = 0.004 (slow myofibers) and 41 [39-48] vs. 27 pL, p = 0.001 (fast myofibers) of control patients and ICU patients with atrophy, respectively). Increased intrinsic apoptotic pathway activation was identified as a mechanism underlying myonuclear removal (percentage of apoptotic myonuclei of 0.64 [0.60-0.84] and 0.95 [0.84-1.2], p = 0.015 and increased percentage of activated caspase-3 positive myonuclei of 2,5 [1.6-3.3] vs. 5.7 [4.3-11], p = 0.001 in control patients and ICU patients with atrophy, respectively). Total transcriptional activity in myofibers decreased with myonuclear loss (RNA-Pol-2 Ser5 fluorescence intensity per fibre of 2.6 [2.2-3.3] vs. 5.8 [3.1-6.7] AU, p = 0.036 in control patients and ICU patients with atrophy, respectively). Furthermore, muscle stem cell number was reduced in the patients with diaphragm atrophy (PAX7 positive nuclei per myofiber of 0.10 [0.09-0.11] vs. 0.05 [0.04-0.07], p = 0.002 in control patients and ICU patients with atrophy, respectively). No correlation was found between myonuclear loss and duration or mode of mechanical ventilation.
CONCLUSIONS: We identified myonuclear loss due to intrinsic apoptotic pathway activation as a potential mechanism underlying diaphragm atrophy in mechanically ventilated patients. The loss of myonuclei may contribute to impaired regeneration of myofibers after critical illness. Duration and mode of mechanical ventilation are not the major drivers of these modifications.